NEVOLA, RICCARDO
 Distribuzione geografica
Continente #
EU - Europa 2.644
AS - Asia 1.284
NA - Nord America 954
SA - Sud America 185
AF - Africa 15
OC - Oceania 1
Totale 5.083
Nazione #
RU - Federazione Russa 2.029
US - Stati Uniti d'America 911
SG - Singapore 410
CN - Cina 277
IT - Italia 266
VN - Vietnam 214
HK - Hong Kong 167
BR - Brasile 155
IE - Irlanda 105
DE - Germania 78
KR - Corea 69
IN - India 48
JP - Giappone 37
NL - Olanda 28
CA - Canada 26
GB - Regno Unito 23
FR - Francia 22
FI - Finlandia 20
PL - Polonia 14
BD - Bangladesh 12
MX - Messico 12
ES - Italia 11
AR - Argentina 9
CZ - Repubblica Ceca 9
AT - Austria 8
TR - Turchia 8
CO - Colombia 6
ID - Indonesia 6
BE - Belgio 5
EC - Ecuador 5
MA - Marocco 5
PT - Portogallo 5
IQ - Iraq 4
LT - Lituania 4
UA - Ucraina 4
ZA - Sudafrica 4
BO - Bolivia 3
CH - Svizzera 3
SA - Arabia Saudita 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
DO - Repubblica Dominicana 2
HR - Croazia 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
MO - Macao, regione amministrativa speciale della Cina 2
NP - Nepal 2
PK - Pakistan 2
SE - Svezia 2
TH - Thailandia 2
TW - Taiwan 2
UY - Uruguay 2
UZ - Uzbekistan 2
AL - Albania 1
AU - Australia 1
BG - Bulgaria 1
CI - Costa d'Avorio 1
CL - Cile 1
CY - Cipro 1
DK - Danimarca 1
DM - Dominica 1
EG - Egitto 1
ET - Etiopia 1
GE - Georgia 1
GR - Grecia 1
HN - Honduras 1
IL - Israele 1
IR - Iran 1
JO - Giordania 1
KE - Kenya 1
KH - Cambogia 1
LY - Libia 1
MD - Moldavia 1
OM - Oman 1
PE - Perù 1
PY - Paraguay 1
RO - Romania 1
SR - Suriname 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
VE - Venezuela 1
Totale 5.083
Città #
Moscow 728
Singapore 192
San Jose 180
Hong Kong 163
Dublin 104
Hefei 81
Ashburn 78
Santa Clara 78
Naples 74
Ho Chi Minh City 67
Seoul 67
The Dalles 64
New York 56
Hanoi 52
Chandler 45
Bengaluru 37
Munich 33
Dallas 28
Beijing 25
Los Angeles 22
Amsterdam 18
Da Nang 16
Milan 15
São Paulo 14
Frankfurt am Main 13
Helsinki 12
Montreal 12
Boardman 10
Florence 10
Haiphong 10
Orem 10
Atlanta 8
Chicago 8
Falkenstein 8
Warsaw 8
Bremen 7
Cambridge 7
Guastalla 7
Liveri 7
Rome 7
Hillsboro 6
London 6
Princeton 6
Roxbury 6
Toronto 6
Belo Horizonte 5
Brooklyn 5
Brussels 5
Ercolano 5
Lappeenranta 5
Memphis 5
Nuremberg 5
Paris 5
Phoenix 5
Thái Nguyên 5
Tokyo 5
Bexley 4
Boston 4
Buffalo 4
Chennai 4
Hải Dương 4
Istanbul 4
Mexico City 4
Mumbai 4
Prague 4
Shanghai 4
Ankara 3
Aversa 3
Baghdad 3
Beaverton 3
Boydton 3
Brasília 3
Brno 3
Can Tho 3
Casablanca 3
Dhaka 3
Eboli 3
La Paz 3
Phủ Lý 3
Piscataway 3
Quito 3
Quận Bình Thạnh 3
Salerno 3
Salvador 3
San Francisco 3
Seattle 3
Secaucus 3
Shenzhen 3
Tianjin 3
Turku 3
Vienna 3
Wroclaw 3
Yên Bái 3
Afragola 2
Araguatins 2
Baku 2
Banda Aceh 2
Barlassina 2
Biên Hòa 2
Bonea 2
Totale 2.601
Nome #
Application and internal validation of lung ultrasound score in COVID-19 setting: The ECOVITA observational study 198
Association between Renal Function at Admission and COVID-19 in-Hospital Mortality in Southern Italy: Findings from the Prospective Multicenter Italian COVOCA Study 183
Non-invasive respiratory support in SARS-CoV-2 related acute respiratory distress syndrome: when is it most appropriate to start treatment? 182
Predictors of in-hospital mortality of COVID-19 patients and the role of telemetry in an internal medicine ward during the third phase of the pandemic 166
Epidemiology of HCV and HBV in a High Endemic Area of Southern Italy: Opportunities from the COVID-19 Pandemic—Standardized National Screening or One Tailored to Local Epidemiology? 165
Cardiorenal Impact of SGLT-2 Inhibitors: A Conceptual Revolution in The Management of Type 2 Diabetes, Heart Failure and Chronic Kidney Disease 163
COVID-19 and arrhythmia: The factors associated and the role of myocardial electrical impulse propagation. An observational study based on cardiac telemetric monitoring 161
HBV Infection and Host Interactions: The Role in Viral Persistence and Oncogenesis 158
ULTRASOUND TIPS IN THE LUNG CANCER DIAGNOSIS: A PILOT STUDY 158
Predictors of early and late hepatocellular carcinoma recurrence 155
Mortality and risk factors of vaccinated and unvaccinated COVID-19 frail patients treated with anti-SARS-CoV-2 monoclonal antibodies. A real-world study 154
Efficacy and safety of the sofosbuvir/velpatasvir combination for the treatment of patients with early mild to moderate COVID-19 152
Factors affecting long-term changes of liver stiffness in direct-acting anti-hepatitis C virus therapy: a multicenter prospective study 151
Remdesivir plus dexamethasone versus dexamethasone alone for the treatment of COVID-19 patients requiring supplemental O2 therapy: a prospective controlled non-randomized study 149
Metabolic dysfunction-associated steatotic liver disease (MASLD): a systemic disease with a variable natural history and challenging management 148
GLP-1 Receptor Agonists in Non-Alcoholic Fatty Liver Disease: Current Evidence and Future Perspectives 144
Lack of effect on in-hospital mortality of drugs used during COVID-19 pandemic: Findings of the retrospective multicenter COVOCA study 140
Neoadjuvant and Adjuvant Systemic Therapies in Loco-Regional Treatments for Hepatocellular Carcinoma: Are We at the Dawn of a New Era? 139
Long-Term Prognosis among COVID-19 Patients: The Predictive Role Played by Hyperinflammation and Arrhythmic Disorders in Fatal Outcome 139
Gender Differences in the Pathogenesis and Risk Factors of Hepatocellular Carcinoma 134
Directly acting antiviral-based treatment for hcv-infected persons who inject drugs: A multicenter real-life study 134
Sodium-Glucose Co-Transporters Family: Current Evidence, Clinical Applications and Perspectives 133
Impact of Acute Kidney Injury on the COVID-19 In-Hospital Mortality in Octogenarian Patients: Insights from the COVOCA Study 132
Impact of chronic liver disease on SARS-CoV-2 infection outcomes: Roles of stage, etiology and vaccination 130
Impact of liver fibrosis on COVID-19 in-hospital mortality in Southern Italy 130
Efficacy and durability of multifactorial intervention on mortality and MACEs: a randomized clinical trial in type-2 diabetic kidney disease 128
Alcohol Consumption and Liver Metabolism in the Era of MASLD: Integrating Nutritional and Pathophysiological Insights 126
Liver Involvement during SARS-CoV-2 Infection Is Associated with a Worse Respiratory Outcome in COVID-19 Patients 125
The number of risk factors not at target is associated with cardiovascular risk in a type 2 diabetic population with albuminuria in primary cardiovascular prevention. Post-hoc analysis of the NID-2 trial 125
Non-alcoholic Fatty Liver Disease (NAFLD), Type 2 Diabetes, and Non-viral Hepatocarcinoma: Pathophysiological Mechanisms and New Therapeutic Strategies 115
Changes in clinical scenarios, management, and perspectives of patients with chronic hepatitis C after viral clearance by direct-acting antivirals 114
ULTRASOUND TIPS IN THE LUNG CANCER DIAGNOSIS: A PILOT STUDY 111
The Cross-Talk Between the Heart and the Liver: The Involvement of the Mitral Valve as a Novel Actor upon the Ancient Scene of Liver Cirrhosis 94
Myosteatosis is closely associated with sarcopenia and significantly worse outcomes in patients with cirrhosis 91
Metabolic Rewiring of Bacterial Pathogens in Response to Antibiotic Pressure—A Molecular Perspective 87
Multidrug-Resistant Infections and Metabolic Syndrome: An Overlooked Bidirectional Relationship 87
The transition from NAFLD to MASLD: implications for Diagnosis, Prognosis, and Clinical Management 81
The Intestinal Thread of Fate: How the Microbiota Shapes the Story of Liver Disease 62
Totale 5.144
Categoria #
all - tutte 15.434
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.434


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202256 0 0 0 1 3 0 2 1 5 17 5 22
2022/2023250 10 3 13 14 30 30 2 14 95 14 14 11
2023/2024288 29 9 20 36 49 54 3 7 4 14 23 40
2024/2025785 7 15 15 21 127 54 81 76 152 81 79 77
2025/20263.765 196 247 228 147 342 1.861 250 143 140 95 58 58
Totale 5.144